Colin Baigent
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management 13
-
- Antiplatelet Therapy and Cardiovascular Diseases 28
- Blood Pressure and Hypertension Studies 16
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes 21
- Dialysis and Renal Disease Management 19
- Surgery top 0.05%
- Lipoproteins and Cardiovascular Health 34
-
- Health Systems, Economic Evaluations, Quality of Life 24
-
- Inflammatory mediators and NSAID effects 15
- Co-authors
- Lisa BlackwellAnthony KeechJonathan EmbersonCarlo PatronoPatricia M. KearneyRory CollinsPeter SleightAdrienne Kirby
- Cited by
- Internal MedicineCardiology and Cardiovascular MedicineEndocrinology, Diabetes and Metabolism
- Journals
- European Heart Journal (13 papers)The Lancet (13 papers)American Journal of Kidney Diseases (8 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Colin Baigent
131 papers receiving 21.8k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Internal Medicine 1.6k
- Cardiology and Cardiovascular Medicine 8.9k
- Endocrinology, Diabetes and Metabolism 4.7k
- Nephrology 1.9k
- Surgery 11.0k
Countries citing papers authored by Colin Baigent
This map shows the geographic impact of Colin Baigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Baigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Baigent more than expected).
Fields of papers citing papers by Colin Baigent
This network shows the impact of papers produced by Colin Baigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Baigent. The network helps show where Colin Baigent may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Colin Baigent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemiasbreakdown → | 2025 | 16 |
| 3 | 2025 | 2 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 4 | |
| 8 | 2020 | 26 | |
| 9 | 2020 | 42 | |
| 10 | Impact of the COVID-19 pandemic on admission rates for, and management of, acute coronary syndromes in England. | 2020 | 2 |
| 11 | 2018 | 120 | |
| 12 | Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials | 2014 | 1 |
| 13 | CANCER AND CHRONIC KIDNEY DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF 33,618 PARTICIPANTS | 2014 | 3 |
| 14 | Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials | 2009 | 13 |
| 15 | Effect of statins on ventricular arrhythmic events: a collaborative meta-analysis of randomised controlled trials | 2009 | 1 |
| 16 | 2006 | 74 | |
| 17 | Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsbreakdown → | 2005 | 4980 |
| 18 | 2004 | 16 | |
| 19 | Efficacy and safety of simvastatin and safety of low-dose aspirin among patients with chronic kidney disease: Final results of the first UK-Heart and Renal Protection (UK-HARP-1) study. | 2002 | 5 |
| 20 | The adverse effects of different doses of aspirin: a systematic overview of randomised trials and observational studies | 2000 | 5 |
About Colin Baigent
Colin Baigent is a scholar working on Nephrology, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 136 papers that have together received 22.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (34 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers), Health Systems, Economic Evaluations, Quality of Life (24 papers), Chronic Kidney Disease and Diabetes (21 papers), Dialysis and Renal Disease Management (19 papers), Blood Pressure and Hypertension Studies (16 papers), Inflammatory mediators and NSAID effects (15 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). The work is most often cited by research in Internal Medicine (1.6k citations), Cardiology and Cardiovascular Medicine (8.9k citations) and Endocrinology, Diabetes and Metabolism (4.7k citations). Colin Baigent has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Lisa Blackwell, Anthony Keech, Jonathan Emberson, Carlo Patrono, Patricia M. Kearney, Rory Collins, Peter Sleight, Adrienne Kirby, John Simes and Christina Reith. Their work appears in journals such as European Heart Journal, The Lancet, American Journal of Kidney Diseases, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.